ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Autonomy Versus Paternalism in Latin America

Autonomy Versus Paternalism in Latin America

In this paper, Dr. Cherny beautifully reviews how to balance the patient's right to be adequately informed about his or her disease with the powerful cultural beliefs held in many parts of the world. This is certainly one of the most difficult tasks in the patient-oncologist relationship. The disclosure of prognostic information to terminally ill patients has emerged within the last 15 years as an important issue, given the greater demands for patient involvement in medical decision making, particularly in the United States.[1] With the evolving emphasis on individual autonomy and freedom, medical paternalism is no longer unquestioningly accepted by society as the principal mode of decision making in health care.[2]

The disclosure of prognosis, even when poor and not completely accurate, is considered ethically justified because it enables patients to exert their autonomy and make treatment decisions that are in alignment with their own goals.[3] Nevertheless, emerging evidence suggests that, too often, realistic conversations about prognosis, the potential benefits and limitations of disease-directed therapy, and the potential role of palliative care occur sporadically and frequently late in the course of the disease.[4-6]

While a patient's autonomy is held in high regard in the United States, in many cultures and particularly in Latin America, the number of physicians, and families, who believe in paternalism as a form of beneficence is still significant. With the aim of assuring a patient's welfare, physicians may voluntarily withhold information on diagnosis and prognosis, which may in some way interfere with or overrule the patient's preferences.[7]

In this cultural scenario, the illness is commonly considered a shared responsibility of the family. Family members, because of their presumed awareness of the patient's needs, goals, and preferences, play a crucial role in decision making, even when the patient is fully competent, and doctors are often not expected to inform patients that they have a terminal illness.[8-12]

In a small Brazilian study, 38 physicians caring for cancer patients in a tertiary hospital responded to a questionnaire addressing the disclosure of diagnosis and prognosis to the patient. Results showed that 97.4% of the physicians informed their patients of the diagnosis in cases of fatal disease. In cases of adverse prognosis, 63.1% preferred to communicate only with family members, while 31.6% preferred to communicate only with the patient.[7] Paternalism seems to emerge as physicians run out of therapeutic resources. At this point, attitudes become conflicting in relation to the principles of beneficence and autonomy.[7]

An American study showed that most oncologists report disclosing the aspect of a prognosis that involves a cancer's not being curable; however, they tend to avoid using percentages to convey prognosis.[13] Oncologists generally offer information on prognosis to their patients (1) when the patient asks directly about his/her condition, (2) when the physician perceives that the patient has the emotional resources to receive the information, (3) when treatment is not producing the desired results, and (4) when the patient is symptomatic and/or decisions about the treatment must be made. Nevertheless, oncologists' reluctance to disclose the prognosis and thus preserve a patient's hope is held in check by the need to assure that patients have realistic expectations for therapy.[13]

There are two main situations in which not being informed about the diagnosis or prognosis may be ethically justified: (1) when the patient does not wish to know, and (2) when the information delivered may be iatrogenic.[14]

It is worth noting that a patient who desires all the information on his/her diagnosis does not necessarily wish detailed information on his/her prognosis. In fact, most patients feel comfortable with complete information on the diagnosis and partial information on the prognosis.[15]

As for the family, we should consider the afflictions precipitated by being responsible for making decisions. Feelings such as regret and guilt during the course of the patient's disease or after his/her death are not uncommon.[7]

Recent studies in the oncology setting have focused on disclosing [8,16-21] or receiving [22] the news that a cancer has reached its terminal stage, and several clinical guidelines and expert recommendations have been published.[4,23,24]

We believe that an ethical and effective approach is to enhance a patient's autonomy through a medical beneficence that incorporates the patient's values, beliefs, and perspectives, even when these differ from the physician's own beliefs. This is possible through a model of shared decision making in which the patient makes meaningful decisions and final choices empowered by the physician's beneficence.[2,25] For such a model to function effectively, the restoration of trust in the doctor-patient relationship, respect, and the adoption of patient-centered communication are essential.[2,4]

Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

References

REFERENCES

1. Lynn J, Teno JM, Harrell FEJ. Accurate prognostications of death. Opportunities and challenges for clinicians. West J Med. 1995;163:250-7.

2. Chin JJ. Doctor-patient relationship: from medical paternalism to enhanced autonomy. Singapore Medical J. 2002;43:152-5.

3. Annas GJ. Informed consent, cancer, and truth in prognosis. N Engl J Med. 1994;330:223-5.

4. Peppercorn JM, Smith TJ, Helft PR, et al. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29;755-60.

5. Keating NL, Landrum MB, Rogers SOJ, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116:998-1006.

6. Stubenrauch JM. Study: Few physicians discussing end-of-life options with advanced-stage patients. Oncology Times. 2010;32:26.

7. Trindade ES, Azambuja LEO, Andrade JP, Garrafa V. (2007). O médico frente ao diagnóstico e prognóstico do câncer avançado. Rev Assoc Med Bras. 2007;53:68-74.

8. Yun YH, Kwon YC, Lee MK, Lee WJ. Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol. 2010;28:1950-7.

9. Leung KK, Liu WJ, Cheng SY, Chiu TY. What do laypersons consider as a good death? Support Care Cancer. 2009;17:691-9.

10. Fallowfield L. Learning how to communicate in cancer settings. Support Care Cancer. 2005;13:349-50.

11. Jiang Y, Liu C, Li JY, et al. Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. PsychoOncology. 2007;16:928-36.

12. Mystakidou K, Parpa E, Tsilika E, et al. Cancer information disclosure in different cultural contexts. Support Care Cancer. 2004;12:147-54.

13. Gordon EJ, Daugherty CK. 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003;17:142-68.

14. Da Silva CH, Cunha RL, Tonaco RB, et al. Not telling the truth in the patient-physician relationship. Bioethics. 2003;17:417-24.

15. Miyata H, Takahashi M, Saito T, et al. Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell? J Med Ethics. 2005;31:447-51.

16. Back AL, Arnold RM. Discussing prognosis: “how much do you want to know?” talking to patients who are prepared for explicit information. J Clin Oncol. 2006;24:4209-13.

17. Bail, WF, Lenzi R, Parker PA, et al. Oncologists' attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189-96.

18. Chiu TY, Hu WY, Cheng SY, Chen CY. Ethical dilemmas in palliative care: a study in Taiwan. J Med Ethics. 2000;26:353-7.

19. Bruera E, Neumann CM, Mazzocato C, et al. Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliat Med. 2000;14:287-98.

20. Blackhall LJ, Murphy ST, Frank G, et al. Ethnicity and attitudes toward patient autonomy. JAMA. 1995;274:820-5.

21. Lorensen M, Davis AJ, Konishi E, Bunch EH. Ethical issues after the disclosure of a terminal illness: Danish and Norwegian hospice nurses' reflections. Nurs Ethics. 2003;10:175-85.

22. Chochinov HM. Dying, dignity, and new horizons in palliative end-of-life care. CA Cancer J Clin. 2006;56:84-103.

23. Morita T, Akechi T, Ikenaga M, et al. Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol. 2004;15:1551-7.

24. Eggly S, Penner L, Albrecht TL, et al. Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines. J Clin Oncol. 2006;4:716-9.

25. Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? BMJ. 1999;319:780-2.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.